Exact Mass: 578.2159
Exact Mass Matches: 578.2159
Found 500 metabolites which its exact mass value is equals to given mass value 578.2159
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pheophorbin a5, dipotassium salt
8-Acetoxypinoresinol 4-glucoside
8-Acetoxypinoresinol 4-glucoside is found in pomes. 8-Acetoxypinoresinol 4-glucoside is a constituent of bark of Olea europaea (olive). Constituent of bark of Olea europaea (olive). 8-Acetoxypinoresinol 4-glucoside is found in pomes.
Netupitant
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Netupitant (CID-6451149) is a highly potent, selective and orally active neurokinin-1 (NK1) receptor antagonist with a Ki of 0.95 nM for hNK1 in CHO cells. Netupitant has antiemetic affect[1][2][3].
gosspyl acetate
R-(-)-Gossypol Acetic Acid is the orally bioavailable solvate of the R-(-) enantiomer of gossypol and acetic acid with potential antineoplastic activity. As a BH3 mimetic, R-(-)-gossypol binds to the hydrophobic surface binding groove BH3 of the anti-apoptotic proteins Bcl-2 and Bcl-xL, blocking their heterodimerization with pro-apoptotic members of the Bcl-2 family of proteins such as Bad, Bid, and Bim; this may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Racemic gossypol is a polyphenolic compound isolated from cottonseed. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively.
(2RS)-2-(3-benzoylphenyl)propionyl beta-D-glucopyranosyl-beta-D-glucopyranoside
(-)-isogaudichaudiic acid B|isogaudichaudiic acid B
(R)-3-(2-((R)-2-((R)-3-(2,4-dihydroxy-6-((R)-2-hydroxypropyl)benzoyloxy)butanoyloxy)propyl)-4,6-dihydroxybenzoyloxy)butanoic acid|15G256pi
(1S,4aS,6R,9S,9aS)-7-{2-[(3R)-2,3-dihydro-3-hydroxy-2-oxo-1H-indol-3-yl]ethyl}-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,8,9,9a-octahydro-6,9-epoxypyrano[3,4-d]azepine-4-carboxylic acid methyl ester|anthocephalusine A
methyl 1alpha-acetoxy-2beta,3alpha,6,8alpha,14beta-pentahydroxy-[4.2.110,30.11,4]-tricyclomeliac-7-oate
benzyl 4-O-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-3-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside|salsaside B
Desoxypodophyllinsaeure-1beta-D-glucopyranosyl-ester; Lignan J|Lignan J
1S-acetyloxy-4S,6R-dihydroxy-9S-benzoyloxy-13-cinnamoyloxy-beta-dihydroagarofuran
(aR)-3,3-Dimethyl-7,7,9,9-tetramethoxy-3,3,4,4-tetrahydro-5,6-bi[1H-naphtho[2,3-c]pyran]-4,4,10,10-tetraol
1alpha,6beta-diacetoxy-9beta,15-dibenzoyloxy-beta-dihydroagarofuran|fokienagarofuran B
3-acetyl-(-)-epicatechin 7-O-[6-(2-methylbutanoyloxy)]-beta-D-glucopyranoside
phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
(1R,2S,3S,4S,5R,7R,9S,10R)-2-acetoxy-1-benzoyloxy-9-cis-cinnamoyloxy-3,4-dihydroxydihydro-beta-agarofuran
kansanoside A|phenylethyl-beta-D-glucopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->6)]-beta-D-galactopyranoside
(1S,4S,5S,6R,7S,8S,9R,10S)-1-acetoxy-9-benzoyloxy-8-cinnamoyloxy-4,6-dihydroxydihydro-beta-agarofuran
7-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranosyldemethoxymatteucinol|miconioside C
3-O-methyl-21,23-dihydro-23-hydroxy-21-oxonomilinic acid
(-)-11,12-dihydro-12-hydroxymorellic acid|(5R,7S,10aS,27S)-11,12-dihydro-12-hydroxymorellic acid|11,12-dihydro-12-hydroxymorellic acid
benzyl 6-O-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-3-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside|salsaside A
Elymoclavine-O-beta-fructofuranosyl-(2->1)-O-beta-D-ructofuranoside
Phellophyll a
gosspyl acetate
R-(-)-Gossypol Acetic Acid is the orally bioavailable solvate of the R-(-) enantiomer of gossypol and acetic acid with potential antineoplastic activity. As a BH3 mimetic, R-(-)-gossypol binds to the hydrophobic surface binding groove BH3 of the anti-apoptotic proteins Bcl-2 and Bcl-xL, blocking their heterodimerization with pro-apoptotic members of the Bcl-2 family of proteins such as Bad, Bid, and Bim; this may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Racemic gossypol is a polyphenolic compound isolated from cottonseed. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively.
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol
C29H38O12_Methyl 2-(hexopyranosyloxy)-4-({6-[2-(4-hydroxyphenyl)ethyl]-4-oxotetrahydro-2H-pyran-2-yl}methyl)-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate
C28H34O13_beta-D-Glucopyranoside, 4-[(1R,3aR,4S,6aS)-6a-(acetyloxy)tetrahydro-4-(4-hydroxy-3-methoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol [IIN-based on: CCMSLIB00000849079]
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol [IIN-based: Match]
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol_major
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol_67.3\\%
Ala Tyr Tyr Tyr
Cys Asp Arg Trp
Cys Asp Trp Arg
Cys Phe Phe Tyr
Cys Phe Tyr Phe
Cys Met Tyr Tyr
Cys Arg Asp Trp
Cys Arg Trp Asp
Cys Trp Asp Arg
Cys Trp Arg Asp
Cys Tyr Phe Phe
Cys Tyr Met Tyr
Cys Tyr Tyr Met
Asp Cys Arg Trp
Asp Cys Trp Arg
Asp Lys Met Trp
Asp Lys Trp Met
Asp Met Lys Trp
Asp Met Gln Trp
Asp Met Trp Lys
Asp Met Trp Gln
Asp Gln Met Trp
Asp Gln Trp Met
Asp Arg Cys Trp
Asp Arg Trp Cys
Asp Trp Cys Arg
Asp Trp Lys Met
Asp Trp Met Lys
Asp Trp Met Gln
Asp Trp Gln Met
Asp Trp Arg Cys
Glu Phe Phe His
Glu Phe His Phe
Glu His Phe Phe
Glu His Met Tyr
Glu His Tyr Met
Glu Met His Tyr
Glu Met Asn Trp
Glu Met Trp Asn
Glu Met Tyr His
Glu Asn Met Trp
Glu Asn Trp Met
Glu Trp Met Asn
Glu Trp Asn Met
Glu Tyr His Met
Glu Tyr Met His
Phe Cys Phe Tyr
Phe Cys Tyr Phe
Phe Glu Phe His
Phe Glu His Phe
Phe Phe Cys Tyr
Phe Phe Glu His
Phe Phe His Glu
Phe Phe Tyr Cys
Phe His Glu Phe
Phe His Phe Glu
Phe Ser Tyr Tyr
Phe Tyr Cys Phe
Phe Tyr Phe Cys
Phe Tyr Ser Tyr
Phe Tyr Tyr Ser
Gly Met Trp Trp
Gly Trp Met Trp
Gly Trp Trp Met
His Glu Phe Phe
His Glu Met Tyr
His Glu Tyr Met
His Phe Glu Phe
His Phe Phe Glu
His Met Glu Tyr
His Met Tyr Glu
His Pro Tyr Tyr
His Tyr Glu Met
His Tyr Met Glu
His Tyr Pro Tyr
His Tyr Tyr Pro
Lys Asp Met Trp
Lys Asp Trp Met
Lys Met Asp Trp
Lys Met Trp Asp
Lys Trp Asp Met
Lys Trp Met Asp
Met Cys Tyr Tyr
Met Asp Lys Trp
Met Asp Gln Trp
Met Asp Trp Lys
Met Asp Trp Gln
Met Glu His Tyr
Met Glu Asn Trp
Met Glu Trp Asn
Met Glu Tyr His
Met Gly Trp Trp
Met His Glu Tyr
Met His Tyr Glu
Met Lys Asp Trp
Met Lys Trp Asp
Met Asn Glu Trp
Met Asn Trp Glu
Met Gln Asp Trp
Met Gln Trp Asp
Met Trp Asp Lys
Met Trp Asp Gln
Met Trp Glu Asn
Met Trp Gly Trp
Met Trp Lys Asp
Met Trp Asn Glu
Met Trp Gln Asp
Met Trp Trp Gly
Met Tyr Cys Tyr
Met Tyr Glu His
Met Tyr His Glu
Met Tyr Tyr Cys
Asn Glu Met Trp
Asn Glu Trp Met
Asn Met Glu Trp
Asn Met Trp Glu
Asn Pro Trp Tyr
Asn Pro Tyr Trp
Asn Trp Glu Met
Asn Trp Met Glu
Asn Trp Pro Tyr
Asn Trp Tyr Pro
Asn Tyr Pro Trp
Asn Tyr Trp Pro
Pro His Tyr Tyr
Pro Asn Trp Tyr
Pro Asn Tyr Trp
Pro Trp Asn Tyr
Pro Trp Tyr Asn
Pro Tyr His Tyr
Pro Tyr Asn Trp
Pro Tyr Trp Asn
Pro Tyr Tyr His
Gln Asp Met Trp
Gln Asp Trp Met
Gln Met Asp Trp
Gln Met Trp Asp
Gln Trp Asp Met
Gln Trp Met Asp
Arg Cys Asp Trp
Arg Cys Trp Asp
Arg Asp Cys Trp
Arg Asp Trp Cys
Arg Trp Cys Asp
Arg Trp Asp Cys
Ser Phe Tyr Tyr
Ser Thr Trp Trp
Ser Trp Thr Trp
Ser Trp Trp Thr
Ser Tyr Phe Tyr
Ser Tyr Tyr Phe
Thr Ser Trp Trp
Thr Trp Ser Trp
Thr Trp Trp Ser
Trp Cys Asp Arg
Trp Cys Arg Asp
Trp Asp Cys Arg
Trp Asp Lys Met
Trp Asp Met Lys
Trp Asp Met Gln
Trp Asp Gln Met
Trp Asp Arg Cys
Trp Glu Met Asn
Trp Glu Asn Met
Trp Gly Met Trp
Trp Gly Trp Met
Trp Lys Asp Met
Trp Lys Met Asp
Trp Met Asp Lys
Trp Met Asp Gln
Trp Met Glu Asn
Trp Met Gly Trp
Trp Met Lys Asp
Trp Met Asn Glu
Trp Met Gln Asp
Trp Met Trp Gly
Trp Asn Glu Met
Trp Asn Met Glu
Trp Asn Pro Tyr
Trp Asn Tyr Pro
Trp Pro Asn Tyr
Trp Pro Tyr Asn
Trp Gln Asp Met
Trp Gln Met Asp
Trp Arg Cys Asp
Trp Arg Asp Cys
Trp Ser Thr Trp
Trp Ser Trp Thr
Trp Thr Ser Trp
Trp Thr Trp Ser
Trp Trp Gly Met
Trp Trp Met Gly
Trp Trp Ser Thr
Trp Trp Thr Ser
Trp Tyr Asn Pro
Trp Tyr Pro Asn
Tyr Ala Tyr Tyr
Tyr Cys Phe Phe
Tyr Cys Met Tyr
Tyr Cys Tyr Met
Tyr Glu His Met
Tyr Glu Met His
Tyr Phe Cys Phe
Tyr Phe Phe Cys
Tyr Phe Ser Tyr
Tyr Phe Tyr Ser
Tyr His Glu Met
Tyr His Met Glu
Tyr His Pro Tyr
Tyr His Tyr Pro
Tyr Met Cys Tyr
Tyr Met Glu His
Tyr Met His Glu
Tyr Met Tyr Cys
Tyr Asn Pro Trp
Tyr Asn Trp Pro
Tyr Pro His Tyr
Tyr Pro Asn Trp
Tyr Pro Trp Asn
Tyr Pro Tyr His
Tyr Ser Phe Tyr
Tyr Ser Tyr Phe
Tyr Trp Asn Pro
Tyr Trp Pro Asn
Tyr Tyr Ala Tyr
Tyr Tyr Cys Met
Tyr Tyr Phe Ser
Tyr Tyr His Pro
Tyr Tyr Met Cys
Tyr Tyr Pro His
Tyr Tyr Ser Phe
Tyr Tyr Tyr Ala
8-Acetoxypinoresinol 4-glucoside
Methyl 2-(hexopyranosyloxy)-4-({6-[2-(4-hydroxyphenyl)ethyl]-4-oxotetrahydro-2H-pyran-2-yl}methyl)-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate
sufentanil citrate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
2-((e)-2-(2-methoxy-3-[(e)-2-(1,3,3-trimethyl-1,3-dihydro-2h-indol-2-ylidene)ethylidene]-1-cyclohexen-1-yl)ethenyl)-1,3,3-trimethyl-3h-indolium perchlorate
Vardenafil HCl Trihydrate
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
2-({6-[(3R)-3-{[3-(2-Cyanobenzyl)-1-methyl-2,6-dioxo-1,6-dihydro-4(2H)-pyrimidinyl]amino}-1-piperidinyl]-3-methyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinyl}methyl)benzonitrile
Propanoic acid, 2,2-dimethyl-, 3-[(2S,5S)-tetrahydro-4-methylene-5-[(3R,5R)-5-methyl-3-[(methylsulfonyl)oxy]-6-[[(trifluoromethyl)sulfonyl]oxy]-6-hepten-1-yl]-2-furanyl]propyl ester
Netupitant
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Netupitant (CID-6451149) is a highly potent, selective and orally active neurokinin-1 (NK1) receptor antagonist with a Ki of 0.95 nM for hNK1 in CHO cells. Netupitant has antiemetic affect[1][2][3].
Orbiculin A
A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by an acetoxy groups at positions 1 and 2 and benzoyloxy groups at positions 6 and 9 (the 1beta,2beta,6alpha,9alpha stereoisomer). Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production.
Ananolignan K
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
2-[(2R,4aR,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
2-[(2S,4aR,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
2-[(2R,4aS,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aS,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4-(dimethylamino)butanamide
2-[(2S,4aS,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aR,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,4aR,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[3-(7-amino-2-tert-butyl-4H-chromen-4-ylidene)prop-1-en-1-yl]-1-(5-carboxypentyl)-3,3-dimethyl-3H-indolium-5-sulfonate
3-[(17S,18R)-8,13-bis(ethenyl)-17-hydroxy-3,7,12,17-tetramethyl-5-oxospiro[22,23-dihydroporphyrin-18,2-oxolane]-2-yl]propanoic acid
3-[(17S,18S)-8,13-bis(ethenyl)-17-hydroxy-3,7,12,17-tetramethyl-5-oxospiro[22,23-dihydroporphyrin-18,2-oxolane]-2-yl]propanoic acid
6-[(2E)-2-[(E)-3-(2-tert-butyl-7-iminochromen-4-yl)prop-2-enylidene]-3,3-dimethyl-5-sulfoindol-1-yl]hexanoic acid
3-Phorbinepropanoic acid, 21-carboxy-9-ethenyl-14-ethyl-4,8,13,18-tetramethyl-20-oxo-, (3S,4S,21R)-
Cyclo(Arg-Gly-Asp-D-Phe-Cys)
Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC), a cyclic RGD peptide which has high affinity to αvβ3, can disrupt cell integrin interactions. Cyclo(Arg-Gly-Asp-D-Phe-Cys) inhibits pluripotent marker expression in embryonic stem cells (ESCs) and the tumorigenic potential of mESCs in vivo. Cyclo(Arg-Gly-Asp-D-Phe-Cys) can be used in the research of tumors[1].
(1s,12r,13s,14s,15s)-12-(acetyloxy)-14-hydroxy-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4,9,11(21),16,18-pentaen-15-yl benzoate
[3,4-dihydroxy-5-({3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)ethoxy]oxan-2-yl}methoxy)oxolan-3-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
methyl 2-[17-(acetyloxy)-6-(furan-3-yl)-10,11,13,14-tetrahydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹²,¹⁷]octadecan-18-yl]-2-hydroxyacetate
8,12-bis(acetyloxy)-7-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
1-{7-methoxy-5'-[(7-methoxy-2-oxochromen-8-yl)methyl]-4',4'-dimethylspiro[chromene-2,2'-[1,3]dioxolan]-8-yl}-3-methyl-2-oxobutyl acetate
(1s,2r,4s,5r,6r,7s,9r,12r)-5,12-bis(acetyloxy)-4-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
methyl 5-ethenyl-4-({6-[2-(4-hydroxyphenyl)ethyl]-4-oxooxan-2-yl}methyl)-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
(1r,2s,3s,4r,5r,6r,7s,9r)-4-(acetyloxy)-2,3-dihydroxy-2,6,10,10-tetramethyl-7-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
(8r,21s)-16,27-dimethoxy-22-methyl-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25(33),26,28(32)-dodecaene-13,26-diol
n-{[(1r,2s,10r,12r,13r,14s)-12-cyano-14-hydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8,16,19-tetraoxo-11,21-diazapentacyclo[11.7.1.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-4(9),6,15(20),17-tetraen-10-yl]methyl}-2-oxopropanamide
(1r,13r,14s,21s)-14,21-dihydroxy-17-[2-(4-methoxyphenyl)ethyl]-6-(2-phenylethyl)-7,12,16-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,5,8,10,15(20),17-hexaene-4,19-dione
4,5-bis(acetyloxy)-12-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
(8r,21s)-13,27-dimethoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-26-ol
2-{[4-hydroxy-4-(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(2-phenylethoxy)oxan-2-yl]methoxy}oxolan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
20,21,25-trimethoxy-8,23-dioxa-15,30-diazaheptacyclo[22.6.2.2⁹,¹².1³,⁷.1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,7(36),9,11,14,18(33),19,21,24(32),25,27(31),34-tridecaen-6-ol
[(2r,3s,4s,5r,6s)-6-{[(2r,3r)-3-(acetyloxy)-2-(3,4-dihydroxyphenyl)-5-hydroxy-3,4-dihydro-2h-1-benzopyran-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2r)-2-methylbutanoate
methyl 5-ethenyl-4-[6-hydroxy-8-(4-hydroxyphenyl)-4-oxooct-2-en-1-yl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
9,20-dimethoxy-15-methyl-7,23,33-trioxa-15,30-diazaoctacyclo[19.9.3.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁴,³².0²⁷,³¹.0²²,³⁴]heptatriaconta-3,5,8(35),9,11,18,20,22(34),24,26,31,36-dodecaen-25-ol
1β,6α-diacetoxy-8β,9β-dibenzoyloxy-β-dihydro-agarofuran
{"Ingredient_id": "HBIN002373","Ingredient_name": "1\u03b2,6\u03b1-diacetoxy-8\u03b2,9\u03b2-dibenzoyloxy-\u03b2-dihydro-agarofuran","Alias": "NA","Ingredient_formula": "C33H38O9","Ingredient_Smile": "CC1CCC(C2(C13C(C(C(C2OC(=O)C4=CC=CC=C4)OC(=O)C5=CC=CC=C5)C(O3)(C)C)OC(=O)C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5291","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}